Gastric mucin is expressed in a subset of endocervical tunnel clusters: Type a tunnel clusters of gastric phenotype

Histopathology

Volumn 50, Issue 7, 2007, Pages 843-850

  Kondo, T ^a,b   Hashi, A ^a   Murata, S I ^a   Fischer, S E ^b   Nara, M ^a   Nakazawa, T ^a   Yuminamochi, T ^a   Hoshi, K ^a   Katoh, R ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Gastric metaplasia; Gastric mucin; HIK1083; Tunnel clusters; Uterine cervix

Indexed keywords

ALCIAN BLUE; STOMACH MUCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCERVICAL TUNNEL CLUSTER; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; INCIDENTAL FINDING; MULTIPARA; PERIODIC ACID SCHIFF STAIN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYLORUS; UTERINE CERVIX DISEASE;

ADULT; AGED; BIOLOGICAL MARKERS; CERVIX UTERI; CYSTS; FEMALE; GASTRIC MUCIN; HUMANS; IMMUNOHISTOCHEMISTRY; METAPLASIA; MIDDLE AGED; PERIODIC ACID-SCHIFF REACTION; PHENOTYPE; UTERINE CERVICAL DISEASES;

EID: 34249792894     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02705.x     Document Type: Article

References (45)

1. Fluhmann CF. Focal hyperplasia (tunnel clusters) of the cervix uteri. Obstet. Gynecol. 1961 17 206 214.
2. Segal GH, Hart WR. Cystic endocervical tunnel clusters. A clinicopathologic study of 29 cases of so-called adenomatous hyperplasia. Am. J. Surg. Pathol. 1990 14 895 903.
3. Jones MA, Young RH. Endocervical type A (noncystic) tunnel clusters with cytologic atypia. A report of 14 cases. Am. J. Surg. Pathol. 1996 20 1312 1318.
4. Nucci MR, Clement PB, Young RH. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am. J. Surg. Pathol. 1999 23 886 891.
5. Nucci MR. Symposium part III: tumor-like glandular lesions of the uterine cervix. Int. J. Gynecol. Pathol. 2002 21 347 359.
6. Schlesinger C, Silverberg SG. Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia. Int. J. Gynecol. Pathol. 1999 18 1 4.
7. Vang R, Vinh TN, Burks RT et al. Pseudoinfiltrative tubal metaplasia of the endocervix: a potential form of in utero diethylstilbestrol exposure-related adenosis simulating minimal deviation adenocarcinoma. Int. J. Gynecol. Pathol. 2005 24 391 398.
8. Young RH, Clement PB. Pseudoneoplastic glandular lesions of the uterine cervix. Semin. Diagn. Pathol. 1991 8 234 249.
9. McCluggage WG, Oliva E, Herrington CS, McBride H, Young RH. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology 2003 43 144 150.
10. McCluggage WG. Endocervical glandular lesions: controversial aspects and ancillary techniques. J. Clin. Pathol. 2003 56 164 173.
11. Bulmer JN, Griffin NR, Bates C, Kingston RE, Wells M. Minimal deviation adenocarcinoma (adenoma malignum) of the endocervix: a histochemical and immunohistochemical study of two cases. Gynecol. Oncol. 1990 36 139 146.
12. Ishii K, Hosaka N, Toki T et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch. 1998 432 315 322.
13. Mikami Y, Hata S, Melamed J, Fujiwara K, Manabe T. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype. Histopathology 2001 39 364 372.
14. Kondo T, Hashi A, Murata S et al. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses. Mod. Pathol. 2005 18 1119 1210.
15. Tsuda H, Okada S, Kasamatsu T. Is florid pyloric metaplasia different from adenoma malignum? Gynecol. Oncol. 2000 77 341 343.
16. Mikami Y, Kiyokawa T, Moriya T, Sasano H. Immunophenotypic alteration of the stromal component in minimal deviation adenocarcinoma ('adenoma malignum') and endocervical glandular hyperplasia: a study using oestrogen receptor and alpha-smooth muscle actin double immunostaining. Histopathology 2005 46 130 136.
17. Ota H, Hayama M, Nakayama J et al. Cell lineage specificity of newly raised monoclonal antibodies against gastric mucins in normal, metaplastic, and neoplastic human tissues and their application to pathology diagnosis. Am. J. Clin. Pathol. 2001 115 69 79.
18. Shaoul R, Marcon P, Okada Y, Cutz E, Forstner G. The pathogenesis of duodenal gastric metaplasia: the role of local goblet cell transformation. Gut 2000 46 632 638.
19. Hayashi I, Tsuda H, Shimoda T. Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix. Am. J. Surg. Pathol. 2000 24 559 562.
20. Sheahan DG, Jervis HR. Comparative histochemistry of gastrointestinal mucosubstances. Am. J. Anat. 1976 146 103 131.
21. Hayashi I, Tsuda H, Shimoda T et al. Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix. Virchows Arch. 2003 443 752 760.
22. Ishii K, Kumagai T, Tozuka M et al. A new diagnostic method for adenoma malignum and related lesions: latex agglutination test with a new monoclonal antibody, HIK1083. Clin. Chim. Acta 2001 312 231 233.
23. Utsugi K, Hirai Y, Takeshima N et al. Utility of the monoclonal antibody HIK1083 in the diagnosis of adenoma malignum of the uterine cervix. Gynecol. Oncol. 1999 75 345 348.
24. Zhao S, Hayasaka T, Osakabe M et al. Mucin expression in nonneoplastic and neoplastic glandular epithelia of the uterine cervix. Int. J. Gynecol. Pathol. 2003 22 393 397.
25. Silverberg SG, Hurt WG. Minimal deviation adenocarcinoma ('adenoma malignum') of the cervix: a reappraisal. Am. J. Obstet. Gynecol. 1975 121 971 975.
26. Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am. J. Surg. Pathol. 1989 13 717 729.
27. Kaminski PF, Norris HJ. Minimal deviation carcinoma (adenoma malignum) of the cervix. Int. J. Gynecol. Pathol. 1983 2 141 152.
28. Kaku T, Enjoji M. Extremely well-differentiated adenocarcinoma ('adenoma malignum') of the cervix. Int. J. Gynecol. Pathol. 1983 2 28 41.
29. Hata S, Mikami Y, Manabe T. Diagnostic significance of endocervical glandular cells with 'golden-yellow' mucin on pap smear. Diagn. Cytopathol. 2002 27 80 84.
30. Lee FD. Pyloric metaplasia in the small intestine. J. Pathol. Bacteriol. 1964 87 267 277.
31. Kurban G, Ishiwata T, Kudo M et al. Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer. Oncol. Rep. 2004 11 987 991.
32. Geboes K, Van den Oord JJ, Rutgeerts P, Desmet VJ, Vantrappen G. Immunohistochemical identification of lysozyme in pseudopyloric gland metaplasia in Crohn's disease. Hepatogastroenterology 1983 30 158 160.
33. Saito H, Maeda A, Ohtomo S et al. Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J. Biol. Chem. 2005 280 2543 2549.
34. Tatematsu M, Ichinose M, Miki K et al. Gastric phenotypic expression in human gallbladder cancers revealed by pepsinogen immunohistochemistry and mucin histochemistry. Virchows Arch. A Pathol. Anat. Histopathol. 1988 413 25 32.
35. Arnaout AH, Abbas SH, Shousha S. Helicobacter pylori is not identified in areas of gastric metaplasia of gall bladder. J. Pathol. 1990 160 333 334.
36. Albores-Saavedra J, Henson DE. Pyloric gland metaplasia with perineural invasion of the gallbladder: a lesion that can be confused with adenocarcinoma. Cancer 1999 86 2625 2631.
37. Schagdarsurengin U, Gimm O, Hoang-Vu C et al. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res. 2002 62 3698 3701.
38. Kodama T, Mori W. Morphological lesions of the pancreatic ducts. Significance of pyloric gland metaplasia in carcinogenesis of exocrine and endocrine pancreas. Acta Pathol. Jpn 1983 33 645 660.
39. Hansen RM, Goriely A, Wall SA, Roberts IS, Wilkie AO. Fibroblast growth factor receptor 2, gain-of-function mutations, and tumourigenesis: investigating a potential link. J. Pathol. 2005 207 27 31.
40. Cubilla AL, Fitzgerald PJ. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res. 1976 36 2690 2698.
41. Luttges J, Reinecke-Luthge A, Mollmann B et al. Duct changes and K-ras mutations in the disease-free pancreas: analysis of type, age relation and spatial distribution. Virchows Arch. 1999 435 461 468.
42. Bakotic BW, Robinson MJ, Sturm PD et al. Pyloric gland adenoma of the main pancreatic duct. Am. J. Surg. Pathol. 1999 23 227 231.
43. Xu JY, Hashi A, Kondo T et al. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int. J. Gynecol. Pathol. 2005 24 296 302.
44. Hashi A, Xu JY, Kondo T et al. p16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia. Int. J. Gynecol. Pathol. 2006 25 187 194.
45. Mikami Y, Kiyokawa T, Hata S et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod. Pathol. 2004 17 962 972.